Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2

Tang Q. et al, (2021), Viruses, 13, 2214 - 2214

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.

Huo J. et al, (2021), Nat Commun, 12

Optimized expression and purification of adipose triglyceride lipase improved hydrolysis and transacylation catalytic activities in vitro.

Kulminskaya N. et al, (2021), The Journal of biological chemistry

The use of nanobodies in a sensitive ELISA test for SARS-CoV-2 Spike 1 protein

Girt GC. et al, (2021), Royal Society Open Science, 8

Architecture of cell-cell junctions in situ reveals a mechanism for bacterial biofilm inhibition.

Melia CE. et al, (2021), Proceedings of the National Academy of Sciences of the United States of America, 118

Cryo-EM structure of PepT2 reveals structural basis for proton-coupled peptide and prodrug transport in mammals

Parker JL. et al, (2021), Science Advances, 7, eabh3355 - eabh3355

Temperature-dependent secretion of Zika virus envelope and non-structural protein 1 in mammalian cells for clinical applications.

Kim YC. et al, (2021), Journal of virological methods, 294

A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19

Huo J. et al, (2021)

Structural basis of antifolate recognition and transport by PCFT

Parker JL. et al, (2021), Nature

SARS-CoV-2 binding to ACE2 triggers pericyte-mediated angiotensin-evoked cerebral capillary constriction

Hirunpattarasilp C. et al, (2021)

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Huo J. et al, (2021), Nature structural & molecular biology

A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.

Tan TK. et al, (2021), Nature communications, 12

Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.

Moreira-Filho JT. et al, (2021), Frontiers in immunology, 12

The structure of nontypeable Haemophilus influenzae SapA in a closed conformation reveals a constricted ligand-binding cavity and a novel RNA binding motif.

Lukacik P. et al, (2021), PloS one, 16

Transient Transfection and Expression of Eukaryotic Membrane Proteins in Expi293F Cells and Their Screening on a Small Scale: Application for Structural Studies.

Krasnoselska GO. et al, (2021), Methods in molecular biology (Clifton, N.J.), 2305, 105 - 128

Human DDX17 Unwinds Rift Valley Fever Virus Non-Coding RNAs.

Nelson CR. et al, (2020), International journal of molecular sciences, 22

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

Graham SP. et al, (2020), npj Vaccines, 5

The structure-function relationship of oncogenic LMTK3.

Ditsiou A. et al, (2020), Science advances, 6

Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2.

Huo J. et al, (2020), Nature structural & molecular biology

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike.

Huo J. et al, (2020), Cell host & microbe, 28

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?